Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
about
Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma.How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.
P2860
Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sentinel node biopsy should be ...... mitotic rate greater than one.
@en
Sentinel node biopsy should be ...... mitotic rate greater than one.
@nl
type
label
Sentinel node biopsy should be ...... mitotic rate greater than one.
@en
Sentinel node biopsy should be ...... mitotic rate greater than one.
@nl
prefLabel
Sentinel node biopsy should be ...... mitotic rate greater than one.
@en
Sentinel node biopsy should be ...... mitotic rate greater than one.
@nl
P1433
P1476
Sentinel node biopsy should be ...... mitotic rate greater than one.
@en
P2093
Melissa A Shearer
Shelley A Sekula-Gibbs
P304
P356
10.1111/J.1524-4725.2011.02015.X
P577
2011-06-02T00:00:00Z